News | Blog

(London, UK) 10 September 2024. Following our recent announcement that hepatoSIGHT has received MHRA UKCA marking, we are excited to share that hepatoSIGHT has now also

(London, UK) 20 August 2024. Predictive Health Intelligence’s flagship product, hepatoSIGHT, a case-finding search engine that enables clinicians to identify people potentially at risk for

Silent plight Our Medical Director Tim Jobson was recently featured in Pharma Times talking about why a new approach is needed for primary biliary cholangitis

Introduction Predictive Health Intelligence (PHI) was established in 2019. What started as an idea and developed into a successful grant application to the National Institute

Predictive Health Intelligence was recently part of a UK government trade delegation to the Arab Health Conference, which took place in Dubai at the end

The Missing Piece in Liver Disease Trials Our Medical Director Tim Jobson was recently featured in the Pharmaceutical Manufacturer talking about the missing piece in

 We are excited to have been chosen by the Department for Business and Trade to be part of the UK government’s trade mission this key

Recently I have been interviewing patients who have been recalled for a review of their liver health using hepatoSIGHT. This is a simple tool that analyses blood tests going back over a number of years and allows a clinician to decide on a cohort of people who might benefit from a more detailed review.

Mark Wall is the Communications Lead for PHI and was part of the team representing the company at the recent EASL conference in Vienna. We

Dr Tim Jobson discusses the early detection of liver disease with Michael Betel of the Fatty Liver Alliance. Check out the entire interview here.